Virology & Mycology Infectious Diseases
 
Untitled Document
   Publications A-Z
A
»Accounting & Marketing
» Addiction Research & Therapy
»Advances in Automobile Engineering
»Advances in Pharmacoepidemiology & Drug Safety
»Advances in Robotics & Automation
»Aeronautics & Aerospace Engineering
»Agrotechnology
»AIDS & Clinical Research
»Allergy & Therapy
»Air & Water borne Diseases
»Alzheimers Disease & Parkinsonism
»Analytical & Bioanalytical Techniques
»Anaplastology
»Anatomy & Physiology
»Andrology-Open Access
»Anesthesia & Clinical Research
»Antivirals & Antiretrovirals
»Applied & Computational Mathematics
»Applied Mechanical Engineering
»Aquaculture Research & Development
»Architectural Engineering Technology
»Arthritis
»Astrophysics & Aerospace technology
»Autacoids
»Autism-Open Access
  
B
»Bacteriology & Parasitology
»Bioanalysis & Biomedicine
»Biochemistry and Analytical Biochemistry
»Biochemistry & Pharmacology: Open Access
»Biochips & Tissue Chips
»Bioenergetics: Open Access
»Bioengineering & Biomedical Science
»Bioequivalence & Bioavailability
»Biofertilizers & Biopesticides
»Biometrics & Biostatistics
»Biomolecules
»Biochemistry & Physiology: Open Access
»Bioprocessing & Biotechniques
»Bioremediation & Biodegradation
»Biosafety
»Biosensors & Bioelectronics
»Biotechnology & Biomaterials
»Bioterrorism & Biodefense
»Blood Disorders & Transfusion
»Blood & Lymph
»Brain Disorders & Therapy
»Briefing in Intellectual Property Rights
»Business and Financial Affairs
  
C
»Cancer Science & Therapy
»Carcinogenesis & Mutagenesis
»Cell and Developmental Biology
»Cell Science & Therapy
»Chemical Engineering & Process Technology
»Chemotherapy: Open Access
»Chromatography & Separation Techniques
»Civil & Environmental Engineering
»Civil & Legal Sciences
»Clinical & Cellular Immunology
»Clinical Case Reports
»Clinical & Experimental Cardiology
»Clinical & Experimental Dermatology Research
»Clinical & Experimental Ophthalmology
»Clinical & Experimental Pathology
»Clinical & Experimental Pharmacology
»Clinical Pharmacology & Biopharmaceutics
»Clinical Research & Bioethics
»Clinical Toxicology
»Clinical Trials
»Cloning & Transgenesis
»Communicable & Noncommunicable Diseases
»Community Medicine & Health Education
»Computer Science & Systems Biology
»Cytology & Histology
D
»Data Mining in Genomics & Proteomics
»Defense Management
»Dentistry
»Depression and Anxiety
»Diabetes & Metabolism
»Drug Designing
»Drug Metabolism & Toxicology
  
E
»Earth Science & Climatic Change
»Ecosystem & Ecography
»Endocrinology & Metabolic Syndrome
»Entomology, Ornithology & Herpetology
»Environmental & Analytical Toxicology
»Epidemiology: Open Access
»Emergency Medicine: Open Access
»Ergonomics
»Electrical & Electronics
»Enzyme Engineering
»Entrepreneurship & Organization Management
  
F
»Fermentation Technology
»Fertilization : In Vitro
»Food Processing & Technology
»Forensic Research
»Forest Research: Open Access
»Fungal Genomics & Biology
  
G
»Gastrointestinal & Digestive System
»Genetic Syndromes & Gene Therapy
»Glycobiology
»Glycomics & Lipidomics
»Gynecology& Obstetrics
»Geography & Natural Disasters
»Geology & Geosciences
»Geophysics & Remote Sensing
»Gerontology & Geriatric Research
  
H
»Hair : Therapy & Transplantation
»Health & Medical Informatics
»Hereditary Genetics
»Homeopathy & Ayurvedic Medicine
»Hotel & Business Management
»Human Genetics & Embryology
»Hydrology: Current Research
»Hypertension- Open Access
  
I
»Industrial Engineering & Management
»Irrigation and Drainage Systems Engineering
»Information Technology & Software
Engineering
»Internal Medicine
  
L
»Liver
  
M
»Marine Science: Research & Development
»Mass Communication & Journalism
»Material Sciences & Engineering
»Medicinal Chemistry
»Medical Advancements in Genetic Engineering
»Medicinal & Aromatic Plants
»Medical Diagnostic Methods
»Medical Microbiology & Diagnosis
»Medical & Surgical Urology
»Membrane Science & Technology
»Metabolic Syndrome
»Metabolomics:Open Access
»Microbial & Biochemical Technology
»Molecular Biology
»Molecular Biomarkers & Diagnosis
»Molecular Imaging & Dynamics
»Mycobacterial Diseases
N
»Nanomedicine & Biotherapeutic Discovery
»Nanomedicine & Nanotechnology
»Neonatal Biology
»Nephrology & Therapeutics
»Neurology & Neurophysiology
»Novel Physiotherapies
»Nuclear Energy & Power Generation
Technologies
»Nuclear Medicine & Radiation Therapy
»Nutrition & Food Sciences
»Nutritional Disorders & Therapy
»Nursing & Care
  
O
»Obesity & Weight loss Therapy
»Outlook on Developing Drugs: Open Access
»Organ Biology
»Organic Chemistry: Current Research
»Orthopedic & Muscular System: Current Research
»Otolaryngology
  
P
»Pain & Relief
»Palliative Care & Medicine
»Pancreatic Disorders & Therapy
»Pediatrics & Therapeutics
»Petroleum & Environmental Biotechnology
»Pharmaceutica Analytica Acta
»Pharmaceutical Regulatory Affairs: Open Access
»Pharmaceutics & Drug Delivery Research
»Pharmacogenomics & Pharmacoproteomics
»Physical Chemistry & Biophysics
»Plant Pathology & Microbiology
»Powder Metallurgy & Mining
»Primatology
»Primary Health Care: Open Access
»Proteomics & Bioinformatics
»Psychology & Psychotherapy
»Pulmonary & Respiratory Medicine
  
R
»Radiology: Open Access
»rDNA Technology
»Reproductive System & Sexual Disorders
»Rheumatology: Current Research
  
S
» Single Cell Genomics & Proteomics
»Sleep Disorders & Therapy
»Social & Economical Issues of Biotechnology
»Socialomics
»Sports Medicine & Doping Studies
»Spine
»Stem Cell Research & Therapy
»Steroids & Hormonal Science
»Stock & Forex Trading
»Surgery: Current Research
  
T
»Telecommunications System & Management
»Textile Science & Engineering
»Thermodynamics & Catalysis
»Thyroid Disorders & Therapy
»Tissue Science & Engineering
»Translational Medicine
»Transplantation Technologies & Research
»Trauma & Treatment
»Tourism & Hospitality
  
V
»Vaccines & Vaccination
»Veterinary Science & Technology
»Virology & Mycology
»Vitamins & Trace Elements
  
W
»Women's Health Care
  
Y
»Yoga & Physical Therapy
 
   Browse by Subjects
Clinical
»Clinical & Experimental Pharmacology
»Forensic Research
»Cell Science & Therapy
»Stem Cell Research & Therapy
»Cancer Science & Therapy
»Carcinogenesis & Mutagenesis
»Cytology & Histology
»AIDS & Clinical Research
»Anesthesia & Clinical Research
»Transplantation Technologies & Research
»Clinical Research & Bioethics
»Clinical & Cellular Immunology
»Clinical & Experimental Cardiology
»Clinical & Experimental Dermatology Research
»Clinical & Experimental Ophthalmology
»Neurology & Neurophysiology
»Clinical & Experimental Pathology
»Pulmonary & Respiratory Medicine
»Clinical Toxicology
  
Pharmaceutical Sciences
»Vaccines & Vaccination
»Antivirals & Antiretrovirals
»Bioanalysis & Biomedicine
»Drug Metabolism & Toxicology
»Bioequivalence & Bioavailability
»Pharmaceutica Analytica Acta
»Pharmaceutics & Drug Delivery Research
»Clinical Pharmacology & Biopharmaceutics
»Outlook on Developing Drugs: Open Access
»Pharmacoepidemiology & Drug Safety
»Pharmaceutical Regulatory Affairs: Open Access
  
Chemistry
»Thermodynamics & Catalysis
»Physical Chemistry & Biophysics
»Organic Chemistry
»Chromatography & Separation Techniques
»Analytical & Bioanalytical Techniques
»Medicinal Chemistry
  
Environmental
»Earth Science & Climatic Change
»Environmental & Analytical Toxicology
»Aquaculture Research & Development
»Hydrology: Current Research
»Petroleum & Environmental Biotechnology
»Ecosystem & Ecography
  
Omics
»Pharmacogenomics & Pharmacoproteomics
»Data Mining in Genomics & Proteomics
»Proteomics & Bioinformatics
»Computer Science & Systems Biology
»Health & Medical Informatics
»Glycomics & Lipidomics
»Metabolomics:Open Access
  
Life Sciences
»Agrotechnology
»Marine Science: Research & Development
»Veterinary Science & Technology
»Plant Pathology & Microbiology
»Nutrition & Food Sciences
»Bioremediation & Biodegradation
»Biometrics & Biostatistics
»Bioengineering & Biomedical Science
»Microbial & Biochemical Technology
»Bioterrorism & Biodefense
»Biofertilizers & Biopesticides
»Social & Economical Issues of Biotechnology
»Biosensors & Bioelectronics
»Nanomedicine & Biotherapeutic Discovery
»Biochips & Tissue Chips
»Molecular Imaging & Dynamics
»Yoga & Physical Therapyy
»Tissue Science & Engineering
»Biotechnology & Biomaterials
»Biochemistry and Analytical Biochemistry
»Nanomedicine & Nanotechnology
»Membrane Science & Technology
»Bacteriology & Parasitology
»Enzyme Engineering
»rDNA Technology
»Cell and Developmental Biology
»Fermentation Technology
»Chemotherapy
»Biochemistry & Physiology
»Biomolecules
»Biochemistry & Physiology: Open Access
»Biochemical Pharmacology
»Bioenergetics
»Forest Research
»Fungal Genomics & Biology
»Medical Advancements in Genetic Engineering
»Biosafety
»Medicinal & Aromatic Plants
» Single Cell Genomics & Proteomics
»Vitamins & Trace Elements
»Women's Health Care
»Primatology
  
Engineering
»Advances in Automobile Engineering
»Advances in Robotics & Automation
»Aeronautics & Aerospace Engineering
»Applied Mechanical Engineering
»Architectural Engineering Technology
»Bioprocessing & Biotechniques
»Chemical Engineering & Process Technology
»Civil & Environmental Engineering
»Electrical & Electronics
»Food Processing & Technology
»Geology and Geosciences
»Geophysics & Remote sensing
»Industrial Engineering & Management
»Information Technology & Software
Engineering
»Irrigation and Drainage Systems Engineering
»Material Sciences& Engineering
»Powder Metallurgy & Mining
»Telecommunications System & Management
»Textile Science & Engineering
  
Medical Sciences
»Genetic Syndromes & Gene Therapy
»Steroids & Hormonal Science
»Virology & Mycology
»Communicable & Noncommunicable Diseases
»Molecular Biomarkers & Diagnosis
»Psychology & Psychotherapy
»Nuclear Medicine & Radiation Therapy
»Alzheimers Disease & Parkinsonism
»Dentistry
»Pediatrics & Therapeutics
»Rheumatology: Current Research
»Hereditary Genetics
»Reproductive System & Sexual Disorders
»Addiction Research & Therapy
»Allergy & Therapy
»Diabetes & Metabolism
»Blood Disorders & Transfusion
»Endocrinology & Metabolic Syndrome
»Nutritional Disorders & Therapy
»Medical Microbiology & Diagnosis
»Human Genetics & Embryology
»Gastrointestinal & Digestive System
»Otolaryngology
»Anatomy & Physiology
»Autacoids
»Sports Medicine & Doping Studies
»Nephrology & Therapeutics
»Community Medicine & Health Education
»Translational Medicine
»Entomology, Ornithology & Herpetology
»Orthopedic & Muscular System
»Epidemiology: Open Access
»Gynecology& Obstetrics
»Mycobacterial Diseases
»Anaplastology
»Surgery: Current Research
»Radiology: Current Research
»Internal Medicine
»Blood & Lymph
»Emergency Medicine
»Fertilization : In Vitro
»Palliative Care & Medicine
»Glycobiology
»Ergonomics
»Liver
»Neonatal Biology
»Medical Diagnostic Methods
»Hair: Therapy & Transplantation
»gerontology & Geriatrics Research
»Andrology
»Clinical Case Reports
»Spine
»Pain & Relief
»Depression and Anxiety
»Obesity & Weight loss Therapy
»Sleep Disorders & Therapy
»Nursing & Care
»Trauma & Treatment
»Primary Health Care: Open Access
»Clinical Trials
»Homeopathy & Ayurvedic Medicine
»Brain Disorders & Therapy
»Pancreatic Disorders & Therapy
»Metabolic Syndrome
»Novel Physiotherapies
»Thyroid Disorders & Therapy
»Air & Water borne Diseases
»Drug Designing
»Molecular Biology
»Cloning & Transgenesis
»Hypertension-Open Access
»Organ Biology
»Arthritis
 
Management
»Accounting & Marketing
»Business and Financial Affairs
»Civil & Legal Sciences
»Defense Management
»Entrepreneurship& Organization Management
»Hotel & Business Management
»Industrial Engineering & Management
»Mass Communication & Journalism
»Stock & Forex Trading
» Socialomics
»Tourism & Hospitality
 
   Conferences
Upcoming Conferences
»International Conference and Exhibition on Metabolomics & Systems Biology 20-22 February 2012 San Francisco, USA.
»2nd World Congress on Pharmaceutics & Novel Drug Delivery Systems 20-22 February 2012 San Francisco, USA.
»International Conference and Exhibition on Biometrics & Biostatistics 5-7 March 2012 Omaha, USA.
»2nd World Congress on Clinical & Experimental Dermatology 5-7 March 2012 Omaha, USA
»2nd World Congress on Clinical & Experimental Cardiology 5-7 March 2012 Omaha, USA.
» 2nd World Congress on Clinical & Experimental Ophthalmology 5-7 March 2012 Omaha, USA.
»International Conference & Exhibition on Nanotechnology and Nanomedicine 12-14 March 2012 Omaha, USA.
»World Congress on Gastroenterology and Urology 12-14 March 2012 Omaha, USA
»3rd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit 26-28 March 2012 Marriott Hotel, Hyderabad, India.
» International Conference and Exhibition on Neurology &Therapeutics 14-16 May 2012 Renaissance Las Vegas Hotel, Las Vegas, Nevada, USA.
»International Conference and Exhibition on Biosensors & Bioelectronics14-16 May 2012 Las Vegas, USA.
»3rd world Congress on Biomarkers & Clinical Research 2-4 July 2012 Las Vegas, USA.
»2nd world Congress on Proteomics & Bioinformatics 2-4 July 2012 Las Vegas, USA.
»International Conference and Exhibition on Orthopedics 13-15 August 2012 Chicago, USA.
»International Conference and Exhibition on Rheumatology and Therapeutics 14-15 August 2012 Chicago, USA.
»International Conference and Exhibition on Addiction Research & Therapy 20-22 August 2012 Las Vegas, USA.
»2nd World Congress on Virology 20-22 August 2012 Las Vegas, USA.
»International Conference and Exhibition on Nephrology and Therapeutics 20-22 August 2012 Hilton Chicago/Northbrook Chicago, USA.
»2nd World Congress on Vaccines & Vaccination 20-22 August 2012 at Chicago, USA.
»World Congress on Earth Science & Climate Change 21-22 August 2012 Chicago, USA.
»International Conference and Exhibition on pathology 27-29 August 2012 Philadelphia, USA.
»International Conference on Pulmonary & Respiratory Medicine 27-29 August 2012 Philadelphia, USA.
»International Conference and Exhibition on Nutritional Science & Therapy-2012 27-29 August 2012 Philadelphia, USA.
»International Conference on Central Nervous System 5-7 September 2012 Double by Hilton Philadephia, USA.
»International Conference on Occupational Health and Safety Summit 5-7 September 2012 Philadelphia, USA.
»International Conference on Hydrology and Groundwater Expo 10-12 September 2012 Hilton San Antonio Airport, USA.
»2nd World Congress on Cancer Science & Therapy 10-12 September 2012 San Antonio, USA.
»World Congress and Expo on Biowaivers and Biosimilars 10-12 September 2012 San Antonio, TX, USA.
»3rd World Congress on Biotechnology 13-15 September 2012 HICC, Hyderabad, India.
»International Conference on Biodiversity & Sustainable Energy Development 14-15 September 2012 Hyderabad, India.
»World Toxicology Summit & Expo-2012 17-19 September 2012 San Antonio Texas, USA.
»International Conference and Exhibition on Translational medicine-2012, 24-26 September 2012 Chicago USA.
»3rd World Congress on Diabetes & Metabolism which is to be held on 24-26 September 2012 Marriott Convention Center, Hyderabad, India.
»International Conference on Tissue Science and Engineering 1-3 October 2012 San Francisco, USA.
»International conference and Exhibition on Pharmacovigilance and Clinical Trials 1-3 October 2012 San Francisco, USA.
»Omics International Integrative Biology Summit 2012 1-3 October 2012 San Francisco, USA.
»International Conference & Exhibition on Emerging Cell Therapies 1-3 October 2012 San Francisco, USA.
»World Congress on Forensic Research & Technology 15-17 October, 2012 at DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference and Exhibition on Otolaryngology 15-17 October 2012 Chicago, USA.
»International conference on Biothreats and Biodefense 15-17 October, 2012 at DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference on Genetic Syndromes & GeneTherapy 22-24 October 2012 at DoubleTree by Hilton Chicago-North Shore, USA.
»International Conference on Clinical and Cellular Immunology 22-24 October 2012 Las Vegas, USA.
»International Conference and Expo on Material science and Engineering 22-24 October 2012 DoubleTree by Hilton Chicago-North Shore, USA.
» International Expo and Conference on Analytrix & HPLC 22-24 October 2012 Hilton Northbrook, Chicago, USA.
»International Conference and Exhibition on Computer Aided Drug Design & QSAR 29-31 October 2012, Chicago, USA.
»World Congress on Personalised Medicine & Molecular Diagnostics 12-14 November 2012 San Antonio, USA.
»2nd World Congress on Cell Science and Stem Cell Research 12-14 November 2012 Hilton San Antonio Airport, USA.
»International Conference on Clinical Microbiology & Microbial Genomics 12-14 November 2012 San Antonio, USA.
»World Congress on Regenerative and Functional Medicine 12-14 November 2012 at San Antonio, Texas, USA.
»Global Biofuels and Bioproducts Summit 19-21 November 2012 San Antonio, USA.
»International Conference and Exhibition on Probiotics-2012, 19-21 November 2012, Hilton San Antonio Airport, USA.
»International Conference and Exhibition on Food Processing and Technology 22-24 November 2012 Hyderabad, India.
»2nd World Congress on Pharmaceutical Regulatory Affairs 23-24 November 2012 HICC Hyderabad, India
»International Conference and Exhibition on Cosmetology & Cosmetics 23-24 November 2012 HICC Hyderabad, India.
»International Conference and Exhibition on Surgery & Transplantation 26-28 November 2012 Hilton San Antonio Airport, USA.
»International conference on Hair Transplantation and Trichology 26-28 November 2012 San Antonio, USA.
»World Congress on Novel approaches in Anaesthesia and Preoperative Care during 26-28 November 2012 San Antonio, USA.
»International Conference on Obesity and Weight Management 3-5 December 2012 Philadelphia, USA.
Previous Conferences Organized/Co-organized
»2nd world Congress on Analytical and Bioanalytical Techniques 16-17 December 2011San franscico, USA.
»2nd World Congress on Diabetes & Metabolism 6-8 December 2011 Philadelphia, USA.
»World Congress on Pediatrics & Gynecology 6-8 December 2011 Philadelphia, USA.
»International Conference and Exhibition on Cell Science & Stem Cell Research 29 Nov-1 Dec 2011 Philadelphia, USA.
»2nd World Congress on Biotechnology 29 Nov -1 Dec 2011 Philadelphia, USA.
»International Conference and Exhibition on Vaccines & Vaccination 22-24 November 2011 Philadelphia, USA.
»2nd World Congress on Biomarkers & Clinical Research 12-14 September 2011 Baltimore, USA.
»International Conference and Exhibition on Virology 5-7 September 2011 Baltimore, USA.
»International Conference and Exhibition on Pharmaceutical Regulatory Affairs 6-7 September 2011 Baltimore, USA.
»International Conference and Exhibition on Cancer Science & Therapy 15-17 August 2011 Las Vegas, USA.
»International Conference on Clinical Research: Dermatology, Ophthalmology and Cardiology 5-6 July 2011 San Francisco, USA.
»International Conference & Exhibition on Proteomics & Bioinformatics 6-8 June 2011 HICC, Hyderabad, India.
»International Conference & Exhibition on Pharmaceutical Biotechnology 6-8 June 2011 HICC, Hyderabad, India.
»2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit 6-8 June 2011 Las Vegas, USA.
»International Conference on Pharmaceutics & Novel Drug Delivery Systems 7-8 June Las Vegas, USA.
»World Congress on Biotechnology 21-23 March 2011 Hyderabad, India.
»International Conference on Diabetes and Metabolism 13-14 December 2010 Santa Clara, USA.
»International Conference on Biomarkers & Clinical Research 22-23 November 2010 Santa Clara, USA
»International Conference and Exhibition on Analytical and Bioanalytical Techniques: Pharmaceutical R & D Summit 01 - 03 November 2010 Hyderabad, India
»International Conference & Exhibition on Bioequivalence & Bioavailability 2010, Pharmaceutical R & D Summit March 01-03, 2010.
»Integrating Glycomics with other Omics in Cancer Detection and Diagnosis, January 19-20, 2010, Stanford University School of Medicine.
»3rd World Congress of Gene-2009, December 1-7, 2009.
»7th Annual World Congress of International Drug Discovery Science & Technology, October 22-25.
»2nd WSA-2009, July 18-20, 2009
»1st CCSB-2009, February 16-17, 2009
»2nd PRICPS-4th AOHUPO, June 22-26, 2008
»95th ISCA, January 5-8, 2008

Search :     Advanced Search 

Home   |   Join   |   Contact     

    
Journal Details
 
 
Research Article Open Access
A Novel Thermostability Conferring Property of Cherry Tag and its Application in Purification of Fusion Proteins
Krishna Mohan Padmanabha Das, Shruti Barve, Sampali Banerjee,
Suman Bandyopadhyay and Sriram Padmanabhan*
Lupin Limited, Biotech R & D, Gat #1156 Ghotawade Village, Mulshi Taluka, Pune-411042, India
*Corresponding author: Dr. Sriram Padmanabhan,
Director, Biotechnology R & D Lupin Limited,
Gat #1156, Ghotawade Village, Mulshi Taluka,
Pune-411042, India,
Tel: + 91-20-66549801,
Fax: + 91-20- 66549807,
E-mail: srirampadmanabhan@lupinpharma.com
 
Received December 08, 2009; Accepted December 26, 2009; Published December 26, 2009
(20
Citation: Das KMP, Barve S, Banerjee S, Bandyopadhyay S, Padmanabhan S 09) A Novel Thermostability Conferring Property of Cherry Tag and its Application in Purification of Fusion Proteins. J Microbial Biochem Technol 1: 059-063. doi:10.4172/1948-5948.1000012
 
Copyright: © 2009 Das KMP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 
Abstract
 
Cherry tag, a red polypeptide of the heme binding part of cytochrome is used to attain high levels of soluble protein expression in E. coli. A novel heat stability conferring property of this tag was observed and studied for constructs of two soluble fusions especially Cherry-Granulocyte colony stimulating factor (GCSF) and Cherry- Staphylokinase (SAK). Heat incubation of these fusion proteins at 70°C for 20 minutes culminated in specific denaturation and precipitation of E. coli proteins excluding the fusion proteins. Both the heat treated fusion proteins were found to be functionally active. Thus Cherry fusion tag could be used as a cost-efficient tool in purification of proteins by imparting heat stability.
 
Keywords
 
Cherry vector; Fusion tag; Thermostability; GCSF; Staphylokinase; Heat treatment
 
Introduction
 
Gene fusion is a successful approach used for producing soluble heterologous proteins in E. coli (Uhl’en and Moks, 1990). A couple of carrier proteins that are widely used in gene fusions include thioredoxin (Trx), maltose-binding protein (MBP), glutathione S-transferase (GST), intein, calmodulin-binding protein (CBP), N utilization substance A (NusA), cellulose-associated protein (CAP) etc. In spite of the fact that the use of these carrier proteins has resulted in successful over expression of many heterologous proteins, each of these tags were assessed empirically and certainly do not possess maximum solubilizing features (Shih et al., 2002).
 
The Cherry™ Express vector, from Eurogentec, USA is one such vector which is being used for similar purposes. This vector possesses a small sequence encoding a red polypeptide of the heme binding part of cytochrome under T7 promoter coding for a protein of molecular mass 11 kDa. This tag favours the solubility of any protein fused to its C terminal portion and appears red on expression allowing one to explicitly and accurately quantify the concentration of target protein by a simple absorbance measurement at 413 nm. The red color constitutes a visual marker throughout protein purification and this tag is cleaved using enterokinase enzyme resulting in authentic N terminal sequence of the target protein (http://www.eurogentec.com/product/research-cherryexpress.html).
 
In an effort to attain large quantities of proteins for structural, functional and other characterization studies, we constructed pSCherry1-GCSF and pSCherry1-SAK cassettes and expressed them in a suitable bacterial host. We noticed a unique heat stable property of such fusion proteins. Since both native GCSF and SAK proteins are thermolabile, we investigated the advantages of use of the heat stability conferring property of Cherry tag on these proteins and implications of our findings are discussed in this paper.
 
High-temperature precipitation is a well demonstrated technique that is usually employed in the initial stages of purification of thermostable proteins (Takesewa et al., 1990; Kirk and Cowan, 1995; Ng et al., 2006). A distinctive use of protein heating was recently illustrated as a protein-purification polishing step to increase the diffraction quality of protein crystals (Pusey et al., 2005). The method is based on the assumption that improperly folded proteins are less heat-stable and have a higher propensity for aggregation than correctly folded proteins. Heating will thus precipitate misfolded proteins, thereby increasing the protein-solution uniformity of the residual protein and apparently the crystal quality (Karlsson and Eriksson, 2007).
 
To investigate the effect of heat treatment on the activity of the fused proteins of interest, we undertook a detailed study of purification and assessment of biological activity of one of the fusion proteins, Cherry-SAK, following thermal treatment at 70°C for 20 minutes and compared its purification profile with that of heat untreated Cherry-SAK fusion protein together with the untagged SAK protein.
 
Materials and Methods
 
Bacterial strains and plasmids
 
Escherichia coli DH5a cells were used for propagation of plasmids. The restriction enzymes were procured from Bangalore Genei Pvt. Ltd, Bangalore, India. BL21(DE3) and BL21(DE3) codon plus cells were purchased from Stratagene, USA while the oligos, PCR extraction kit and Genelute kit and other fine chemicals were purchased from Sigma, USA. The anion exchanger matrix Q Sepharose FF was from GE Healthcare, Sweden.
 
Cloning of pSCherry1-GCSF and pSCherry1-SAK constructs
 
hGCSF gene was amplified by polymerase chain reaction (PCR) using synthetic hGCSF gene as a template (Somani et al., 2009). The sequence of the forward and the reverse primers were 5´ CCG CCG GGA TCC GAT GAT GAT GAT AAA ACG CCA TTA GGC CCG GCC 3´ and 5´ CCG CCG GAA TTC AAG CTT TTA CGG CTC CGC TAA ATG ACG 3´, respectively. The digested PCR product was cloned into pSCherry1 vector as a BamHI/EcoRI fragment.
 
Staphylokinase gene was amplified by PCR from the synthetic SAK gene as described (Mandi et al, 2009). The oligos of the sequence 5´ CCG CCG GAA TTC CAT ATG TCA AGT TCA TTC GAC AAA GGA 3’ and 5´ CCG CCG GAA TTC AAG CTT TTA TTT CTT TTC TAT AAC AAC 3´ were used as forward and reverse primers, respectively. The amplified PCR product was purified and cloned into pSCherry1 vector as an NdeI/ HindIII fragment.
 
Shake flask expression studies of Cherry-GCSF and Cherry- SAK and sub cellular localization
 
pSCherry1-SAK and pSCherry1-GCSF clones were introduced into BL21 (DE3) Codon plus and BL21(DE3) cells, respectively and the protein expression was induced with 1 mM IPTG for 4 hours at 37°C. The induced cell pellets were resuspended in 10 mM Tris pH 8.0 at a 1:40 (w/v) ratio and subjected to lysis using a homogenizer (Nano De Bee, Bee Intl, USA) at 25,000 psi for 2 cycles followed by centrifugation at 13,000 rpm for 10 minutes to separate the soluble and insoluble fractions of the harvested cells. All the samples were later analyzed on SDS-PAGE followed by coomassie staining.
 
Heat treatment methodology and analytical methods
 
The clarified cell lysate supernatant was subjected to heat at 70ºC for 20 min containing 100 mM sodium chloride followed by centrifugation at 13,000 rpm for 10 min to separate the heat denatured and the heat stable protein fractions. These fractions were subsequently analyzed on SDS-PAGE (Kirk and Cowan, 1995).
 
The densitometry analysis of the protein of interest was carried out following the method of Catzel et al. (2003). Purified GCSF and SAK protein obtained from the pET21a constructs (Somani et al., 2009; Mandi et al., 2009) (data not shown) were also subjected to heat as specified earlier.
 
Purification of Cherry-SAK fusion and untagged SAK proteins
 
The soluble Cherry-SAK protein, with and without heat treatment, were dialyzed against 100 volumes of 10mM Tris pH 8.0 in cold for 16 h. The dialyzed samples were then loaded onto a Q-Sepharose (anion exchanger) column equilibrated at pH 8.0. After washing the column with 10mM Tris pH 8.0, the bound protein was eluted using a gradient of NaCl solution (0.1 to 1.0 M). Fractions comprising Cherry-SAK were pooled and analyzed on SDS-PAGE. Similar protocol was pursued for untagged SAK protein (without heat treatment) expressed from pET21a- SAK construct (Mandi et al., 2009).
 
Chromogenic assay of SAK
 
SAK activity was quantified using plasminogen coupled chromogenic assay as described by (Apte-Deshpnade et al., 2009). Briefly, 25 mU of human plasminogen, the chromogenic substrate D-Val-Leu-Lys 4-nitroanilide dihydrochloride (Sigma) and samples containing SAK were incubated in 100 μl reaction volume in 96-well flat-bottom plates (Nunc) at 25°C for 20 min. Amount of p-nitroaniline (pNA) released was monitored at 405 nm by plate reader (Multiskan Spectrum, Thermo, USA). One unit (1 U) of SAK is the amount of the enzyme needed to form 1 U of plasmin from plasmingen. Units of plasmin formed were estimated from the amount of chromogen (pNA) formed using a standard curve of pure pNA.
 
Biological activity of Cherry-GCSF using NFS-60 cells
 
In-vitro cell proliferation assays were performed to determine the biological activity of heat treated crude Cherry-GCSF fusion proteins as specified earlier (Somani et al., 2009) with the following modifications. Briefly, the NFS-60 cells were maintained in RPMI medium with 10% fetal calf serum, penicillin (100 units/ml), streptomycin (1mg/ml), L-glutamine (2mM), sodium pyruvate (1 mM) and mouse IL-3 (33U/ml). For proliferation assay, cells were pre incubated for 3 hours in the above medium without IL-3. Subsequently, these cells (2.5 x 104cells/ 100μl) were treated with Cherry- GCSF fusion proteins (250 pg/ ml of GCSF equivalent) in 96-well tissue culture plates for 48 h at 37°C and 5% CO2. The cell proliferation was measured by CCK-8 Kit (Dojindo, Maryland, USA) as per manufacturer’s protocol. Briefly, 10 μl of the assay reagent was added and amounts of formazan formed (an indicator of the number of live cells i.e. biological activity) was estimated by measuring OD at 490 nm after additional 3 hours of incubation.
 
Results
 
The Cherry-GCSF and the Cherry-SAK fusion proteins were found to be localized into the soluble fraction of the cell as represented in the Figure 1 (lanes 3 and 4 respectively). The untagged SAK protein was also a soluble protein (data not shown) as described earlier (Mandi et al., 2009).
 
fig
 Figure 1: Expression of Cherry-SAK and Cherry-GCSF. SDS-PAGE profile of insoluble and soluble fractions of Cherry-SAK and Cherry-hGCSF followed by coomassie blue staining. Lane 1: Protein Molecular weight Marker (14-97 kDa) Lane 2: Insoluble fraction of Cherry-hGCSF, Lane 3: Soluble fraction of Cherry-hGCSF, Lane 4: soluble fraction of Cherry-SAK, Lane 6: insoluble fraction of Cherry-SAK.
 
Upon heat treatment, almost 90% of the Cherry-GCSF fusion protein appeared in the heat treated supernatant (Figure 2a, lane 3) while almost 100% of the SAK protein was present in the heat treated supernatant (Figure 2b, lane 6) as judged by densitometry scanning. The untagged crude SAK protein was, however found to precipitate completely (Figure 2b, lane 4) under similar heating conditions.
 
fig
 Figure 2: Heat denaturation studies in the presence of 0.1 M NaCl. Crude soluble fractions of SAK, Cherry-SAK and Cherry-GCSF were heated to 70°C for 20 minutes followed by centrifugation at 13,000 rpm for 10 min. The cleared heated lysates and the pellets were analyzed by SDS-PAGE followed by commassie blue staining.
A) Lane 1: Molecular weight marker(14-97 kDa), Lane 2: Soluble fraction of Cherry- hGCSF, Lane 3: Heat treated cleared supernatant of Cherry-hGCSF, Lane 4 : Pellet after heat denaturation. B) Lane 1: Molecular weight marker(14-97 kDa), Lane 2: Soluble fraction of SAK, Lane 3 : Heat treated cleared supernatant of SAK, Lane 4: Pellet after heat denaturation, Lane 5: Soluble fraction of Cherry-SAK, Lane 6 : Heat treated cleared supernatant of Cherry-SAK.
 
To gain further insight into thermostable nature of these fusion proteins, we proceeded with purification of Cherry-SAK fusion protein with and without heat treatment. The results indicated (Figure 3) that while the heat treated Cherry-SAK fusion protein showed a purity of 85% (Figure 3b, lane 4), the untreated fusion protein showed merely 35% purity (Figure 3a, lane 3) when purified in the same manner. It is important to emphasize at this stage that irrespective of heat treatment, the binding property of the Cherry-SAK, remained unaltered as reflected from the fact that under both the conditions the proteins were optimally eluted with 300 mM sodium chloride (Figure 3a and 3b). Under similar purification conditions when untagged SAK was loaded on Q Sepharose, the eluted untagged SAK showed merely 13% purity (Figure 3c, lane 3). This result is encouraging since it opens up a new method for purification of all Cherry fused proteins by the methodology followed.
 
fig
 Figure 3: Purification of Cherry-SAK with or without heat treatment and untagged SAK on anion exchange column. A) Cherry-SAK purified on Q Sepharose. Lane 1: Molecular weight marker (14-97 kDa), Lane 2: Soluble fraction of Cherry-SAK cell lysate, Lane 3: 0.3 M NaCl eluate of Q-Sepharose. B) Heat treated Cherry-SAK lysate purified on Q Sepharose. Lane 1: Molecular weight marker (14-97 kDa), Lane 2: Soluble fraction of Cherry-SAK cell lysate, Lane 3: Heat treated cleared supernatant of Cherry-SAK, Lane 4: 0.3 M NaCl eluate of Q-Sepharose. C) Untagged SAK purified on Q Sepharose. Lane 1: Soluble fraction of SAK cell lysate, Lane 2: Molecular weight marker (14-97 kDa), Lane 3: 0.3 M NaCl eluate of Q-Sepharose.
 
It was also intriguing to see that the Cherry-GCSF fusion protein after heat treatment displayed nearly 50% biological activity as shown in Figure 4a in comparison to NIBSC standard while there was no activity for the purified heat treated native GCSF. This suggested that Cherry tag indeed offers heat stability to GCSF when it exists as a fusion protein. Also, the SAK activity of the purified Cherry-SAK fusion protein (Figure 4b, sample 3) was found to be similar to the activity seen with the untreated Cherry-SAK (Figure 4b sample 1). It was interesting to note a marginal increase in the SAK activity for the heat treated Cherry- SAK preparation and this might be due to the deactivation of certain E. coli proteases upon heat treatment (Figure 4b, sample 2). It was also observed that more than 80% of the activity of the purified SAK was lost when it was subjected to the heat treatment under similar experimental conditions (Figure 4b, sample 5).
 
fig
 Figure 4: Activity assay of Cherry-GCSF and Cherry-SAK. A) Biological activity of Cherry-GCSF. Sample 1: NIBSC GCSF standard, Sample 2: Purified GCSF expressed from pET21a-GCSF construct, Sample 3: Purified GCSF heat treated at 70°C for 20 min, Sample 4: Untreated crude Cherry-GCSF fusion protein, Sample 5: Heat treated crude Cherry-GCSF fusion protein. B) Chromogenic assay of Cherry-SAK. Sample 1: Untreated crude Cherry-SAK, Sample 2: Heat treated crude Cherry-SAK, Sample 3: Heat treated purified Cherry-SAK, Sample 4: Purified untagged SAK expressed from pET21a-SAK construct, Sample 5: Heat treated pure untagged SAK.
 
Discussion
 
Fusion tags that allow enhanced recovery using economical purification methods are easily scalable for industrial downstream processing. Some of the fusion tags that promote secretion of target proteins are also useful tags based on assay on enzymatic activity or antibody binding (Ford et al., 1991). Since many fusion tags do not interfere with the biological activity of the target protein and in some cases have actually been shown to stabilize it, they are preferred for hyper expression of proteins (Banerjee et al., 2009). Nevertheless, for the purification of authentic proteins, a site for specific enzyme cleavage is often included, allowing removal of the tag after recovery.
 
We noticed a novel characteristic of Cherry™ tag in conferring heat stability to otherwise heat labile proteins and since this is being stated for the first time, we studied this property in detail. A couple of proteins have been purified using such heat stable properties of the fusion tags include purification of immunoglobulin G from rabbit serum (Osmark et al., 2003), recombinant antibodies purification from Camelidae (VHHs) (Olichon et al., 2007), heat purification of both RE3 and VHs (Marco et al., 2004) and purification and characterization of membrane protein di-geranylgeranylglyceryl phosphate synthase from archaea etc. (Roy et al., 2007). The inherent thermal stability of thioredoxin and its susceptibility to quantitative release from the E. coli cytoplasm by osmotic shock can also be exploited as useful tools for thioredoxin fusion protein purification (McCoy, 2001).
 
The temperatures that have been tried for purification of proteins by heat treatment protocol range from 50 to 80°C. The mechanism that has been attributed to such an effect is that the heat treatment causes permanent unfolding of proteins together with formation of aggregates due to its exposed hydrophobic core with increased entropy. In particular, the fusion proteins are denatured but can correctly refold after withdrawal of heat treatment and this feature enables their differential purification as heating denatures and precipitates thermosensitive bacterial proteins irreversibly (Kwon et al., 2008).
 
A statistical trend seems to appear on the amino acids that contribute to thermostability of proteins especially when one compares the amino acid composition of a mesostable protein with a thermostable protein. The ratio of number of glutamic acid and lysine to glutamine and histidine has also been shown to be a responsible factor for heat stable property of any protein (Farias et al., 2004). The heat stability of the protein is expected to be higher when such a ratio is higher than 2.5. The Cherry tag amino acid sequence exhibited a ratio of 3.0 by this criterion and hence it is tempting to speculate that the number of glutamic acid and lysine could be one of the possible factors responsible for the heat conferring property of the cherry tag reported here. It is interesting to note that the fusion tags such as NusA, GST have different heat stable ratio and hence this criteria could be used for choosing fusion tags for cloning and subsequent purification.
 
The observation of retaining the biological activity of the Cherry fusion protein even after heat treatment demonstrates that the proteins are folded in the right confirmation and indicates that the Cherry tag imparts heat stable property to the proteins illustrated here, since both these proteins are known to be susceptible to heat in their native and untagged state.
 
Heat purification, thus, is not only a fast and economical alternative to conventional chromatography but, when applicable, can also simplify the downstream operations in large scale manufacturing of the recombinant therapeutics. The efficiency of heat purification to eliminate the endotoxins and host cell protein (HCP) load from bacterial recombinant protein preparations also appears to be of prime significance.
 
In summary, we have developed a cost-effective method for purification of proteins expressed in E. coli using the heat conferring property of the Cherry tag. This vector enables us to screen highly soluble proteins effectively and also shows promising potential in purification of the proteins with a simple heat treatment approach, thus reducing the protein load to column chromatographic separations. Similar approach can be applied to alternative cloning of all potential target genes into vectors of different expression systems, including yeast, insect, and mammalian cells, as well as cell-free in vitro systems with this tag with suitable promoter systems. This method also appears well suited for automation and might be a useful tool for the production of proteins for structural and functional genomic studies.
 
Acknowledgements
 
The authors are thankful to Mr. Sachin Rewanwar, Dr. Bhaskarjyoti Prasad and Mr. Srinivasa Kumar for helping us with some experiments. Authors are also thankful to Dr. Kamal Sharma, Managing Director, Lupin Limited, India for his continuous encouragement and support.
 
References
 
  1. Apte-Deshpande A, Mandal G, Soorapaneni S, Prasad BJ, Kumar J, et al. (2009) High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris. Biotechnol Lett 31: 811-817. »  CrossRef  »  PubMed »  Google Scholar

  2. Banerjee S, Apte-Deshpande A, Mandi N, Padmanabhan S (2009) A novel cytokine derived fusion tag for over-expression of heterologous proteins in E. coli. Intl J Biol Life Sci 1: 139-143.  »  Google Scholar

  3. Catzel D, Lalevski H, Marquis CP, Gray PP, Dyk DV, et al. (2003) Purification of recombinant human growth hormone from CHO cell culture supernatant by Gradiflow preparative electrophoresis technology. Protein Express Purif 32: 126-134. »  CrossRef  »  PubMed »  Google Scholar

  4. Farias ST, Linden MG, Rêgo TG, Araújo DAM, Bonato MCM (2004) Thermo-search: lifestyle and thermo stability analysis. In Silico Biology 4: 377-380. »  CrossRef »  Google Scholar

  5. Ford CF, Suominen I, Glatz CE (1991) Fusion tails for the recovery and purification of recombinant proteins. Protein Express Purif 2: 95-107.  »  CrossRef  »  PubMed  »  Google Scholar

  6. Karlsson A, Eriksson AES (2007) Heating of proteins as a means of improving crystallization: a successful case study on a highly amyloidogenic triple mutant of human transthyretin. Acta Crystallogr Sect F Struct Biol Cryst Commun 63: 695-700. »  CrossRef  »  PubMed  »  Google Scholar

  7. Kirk N, Cowan D (1995) Optimizing the recovery of recombinant thermo stable proteins expressed in mesophilic hosts. J Biotechnol 42: 177-184.  »  CrossRef  »  PubMed »  Google Scholar

  8. Kwon S, Jung Y, Lim D (2008) Proteomic analysis of heat-stable proteins in Escherichia coli. BMB Reports 41: 108-111. »  CrossRef  »  PubMed »  Google Scholar

  9. Mandi N, Soorapaneni S, Rewanwar S, Kotwal P, Prasad BJ, et al. (2009) High yielding staphylokinase in bacterial expression system: cloning, expression, purification and activity studies. Protein Express Purif 64: 69-75. »  CrossRef  »  PubMed »  Google Scholar

  10. Marco A, Casatta E, Savaresi S, Geerlof A (2004) Recombinant proteins fused to thermostable partners can be purified by heat incubation. J Biotechnol 107: 125-133.  »  CrossRef  »  PubMed »  Google Scholar

  11. McCoy J (2001) Expression and Purification of thioredoxin fusion Proteins. In: La Ville (ed) Curr Protoc Protein Sci Chapter 6: Unit6-7. »  CrossRef  »  PubMed »  Google Scholar

  12. Ng MYT, Tan WS, Abdullah N, Ling TC, Tey BT (2006) Heat treatment of unclarified E. coli homogenate improved the recovery efficiency of recombinant hepatitis B core antigen. J Virol Meth 137: 134-139.  »  CrossRef  »  PubMed »  Google Scholar

  13. Olichon A, Schweizer D, Muyldermans S, Marco A (2007) Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains. BMC Biotechnol 7: 7. »  CrossRef  »  PubMed »  Google Scholar

  14. Osmark P, Cedervall T, Pieters K, Åkerström B (2003) Heat elution chromatography of immunoglobulins. Protein Express Purif 30: 301-303. »  CrossRef  »  PubMed  »  Google Scholar

  15. Pusey ML, Liu ZJ, Tempel W, Praissman J, Lin D, et al. (2005) Life in the fast lane for protein crystallization and X-ray crystallography. Prog Biophys Mol Biol 88: 359-386.  »  CrossRef  »  PubMed »  Google Scholar

  16. Roy N, Nemoto N, Yamagishi A (2007) cloning, Expression, Purification and Characterization of Membrane Protein Di-geranylgeranylglyceryl Phosphate Synthase from Archaea. Asian J Biochem 2: 152-156.  »  CrossRef »  Google Scholar

  17. Shih YP, Kung WM, Chen JC, Yeh CH, Wang AHJ, et al. (2002) Highthroughput screening of soluble recombinant proteins. Protein Sci 11: 1714- 1719.   »  Google Scholar

  18. Somani S, Mandal G, Banerjee S, Prasad KS, Padmanabhan S (2009) Rapid and sensitive method to detect oxidized forms of rhGCSF using Agilent 2100 Bioanalyzer. Anal Lett 42: 1070-1083.  »  CrossRef  »  Google Scholar

  19. Takesewa Y, Cowan D, Bonnerjea J, Hoare M (1990) Heat-induced precipitation of cell homogenates: An investigation of the recovery of thermostable proteins. Enzyme Microb Technol 12: 184-189. »  CrossRef  »  Google Scholar  

  20. The Cherry™ Express kit is an easy-to-use kit designed for visualizing your protein expression in E. coli. http://www.eurogentec.com/product/researchcherryexpress. html. 

  21. Uhl’en M, Moks T (1990) Gene fusion for purposes of expression: An introduction. Meth Enzymol 185: 129-143. 
 
 
 
This Article
DOWNLOAD
» XML (45kB)
» PDF (715 kB)
» Citation
   
CONTRIBUTE
» Write a Response
» Read other Responses
» Publishing with OPG
   
SHARE
» E-mail This Article
» Print This Article
» Rights and Permissions
   
Share
EXPLORE
Related Article at
» Pubmed
» DOAJ
» Scholar Google
 
 
 
 
Untitled Document
| More
OMICS Publishing Group: An Open Access Publisher
OMICS Publishing Group is the member of/publishing partner of/source content provider to
All Published content, except where otherwise noted, is licensed under a Creative Commons Attribution License.